The GCI Dashboard

Version:
Share: whatsapp
Country Rank

175


Austria

Recovery Rank for 180 countries/regions

Country Rank

173


Austria

Recovery Rank for 184 countries/regions

COVID-19 Recovery Rating

2

Recovery Index
33.06
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Recovery Rating

2

Recovery Index
34.46
(Out of 100)



(100 = Best, 0 = Worst)

COVID-19 Severity Rating

4

Severity Index
65.78
(Out of 100)



(0 = Best, 100 = Worst)

COVID-19 Severity Rating

4

Severity Index
63.64
(Out of 100)



(0 = Best, 100 = Worst)

Stringency Rating

30.43

(100 = Strictest Measures, 0 = No Measures)


Population
8,877,067

(Medium Density)


GNI per capita (US$)

49,350

(High income)
5 Countries who have made the most progress in
curtailing the spread of the pandemic and can be
used as examples of best practices (Relative Rating)
4
3
2 Countries who are struggling to cope with the crisis
and who may need to consider maintaining stringent
non-pharmaceutical measures (Relative Rating)
1
1 Countries who are coping with the crisis with a low percentage
of infections and resulting deaths per population
(Relative Rating)
2
3 Countries who may be overwhelmed by the crisis with a high
percentage of infections and resulting deaths per population
(Relative Rating)
4
5

Travel Advisory


1. Until 9 January 2022, flights from Angola, Botswana, Eswatini, Lesotho, Malawi, Mozambique, Namibia, South Africa, Zambia and Zimbabwe are suspended. - This does not apply to
humanitarian, medevac and repatriation flights.

2. Passengers arriving from or who have been in Angola, Botswana, Denmark, Eswatini, Lesotho, Malawi, Mozambique, Namibia, Netherlands, Norway, South Africa, United Kingdom,
Zambia or Zimbabwe in the past 10 days are not allowed to enter. - This does not apply to: - nationals of Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia,
Finland, France, Germany, Greece, Hungary, Iceland, Ireland (Rep.), Italy, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania,
Slovakia, Slovenia, Spain, Sweden and Switzerland; - residents of Austria; - passengers with a negative COVID-19 LAMP, PCR or TMA test result issued at most 48 hours before arrival
and with a COVID-19 vaccination certificate showing that they received a booster dose; - more exemptions can be found at https://tinyurl.com/8w8kyybv

3. Passengers arriving from or who have been in Angola, Botswana, Denmark, Eswatini, Lesotho, Malawi, Mozambique, Namibia, Netherlands, Norway, South Africa, United Kingdom,
Zambia or Zimbabwe in the past 10 days must have a negative COVID-19 LAMP, PCR or TMA test result issued at most 72 hours before arrival; and - a COVID-19 recovery certificate
issued at most 180 days before arrival; or - a COVID-19 vaccination certificate stating that they received: - the second vaccine dose of AstraZeneca (Vaxzevria), Covaxin,
Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at most 270 days before arrival. A combination of vaccines is accepted; or -
the third vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at least 120 days
after the second dose and at most 270 days before arrival; or - the Janssen vaccine at least 22 days and at most 270 days before arrival; or - the second vaccine dose of Janssen
vaccine at least 14 days after the first dose and at most 270 days before arrival; or - the first vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Moderna
(Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 22 days and at most 270 days before arrival and proof of previous COVID-19 infection; or - the
second vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at least 120 days
after the first dose and at most 270 days before arrival and proof of previous COVID-19 infection; and - are subject to quarantine for 10 days. - This does not apply to: -
passengers younger than 12 years if accompanied by an adult; - passengers with a negative COVID-19 LAMP, PCR or TMA test result issued at most 48 hours before arrival and with a
COVID-19 vaccination certificate showing that they received a booster dose; - passengers between 6 and 15 years, traveling alone if they have a negative COVID-19 LAMP, PCR, TMA
issued at most 72 hours before arrival or a negative Antigen test issued at most 48 hours before arrival. Passengers with a medical certificate of contraindication who cannot be
vaccinated and pregnant women do not need a COVID-19 recovery or vaccination certificate.

4. Passengers must have a negative COVID-19 LAMP, PCR or TMA test result issued at most 72 hours before arrival; or - take a test after arrival; and - have a COVID-19 recovery
certificate issued at most 180 days before arrival; or - have a COVID-19 vaccination certificate stating that they received: - the second vaccine dose of AstraZeneca (Vaxzevria),
Covaxin, Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at most 270 days before arrival. A combination of vaccines is
accepted; or - the third vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac, at
least 120 days after the second dose and at most 270 days before arrival; or - the Janssen vaccine at least 22 days and at most 270 days before arrival; or - the second vaccine
dose of Janssen vaccine at least 14 days after the first dose and at most 270 days before arrival; or - the first vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield,
Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac at least 22 days and at most 270 days before arrival and proof of previous COVID-19
infection; or - the second vaccine dose of AstraZeneca (Vaxzevria), Covaxin, Covishield, Covovax, Moderna (Spikevax), Nuvaxovid, Pfizer-BioNTech (Comirnaty), Sinopharm or Sinovac,
at least 120 days after the first dose and at most 270 days before arrival and proof of previous COVID-19 infection. - This does not apply to: - passengers arriving from Angola,
Botswana, Denmark, Eswatini, Lesotho, Malawi, Mozambique, Namibia, Netherlands, Norway, South Africa, United Kingdom, Zambia or Zimbabwe; - passengers younger than 12 years if
accompanied by an adult; - passengers with a COVID-19 vaccination certificate showing that they received a booster dose; - passengers between 6 and 15 years, if they have a
negative COVID-19 LAMP, PCR, TMA issued at most 72 hours before arrival or a negative COVID-19 antigen test issued at most 48 hours before arrival. Passengers with a medical
certificate of contraindication who cannot be vaccinated and pregnant women do not need a COVID-19 recovery or vaccination certificate.

5. Passengers must present a completed "Pre-Travel-Clearance" upon arrival. The form can be found at https://entry.ptc.gv.at

6. Passengers could be subject to self-quarantine for 10 days. Exemptions can be found at https://tinyurl.com/8w8kyybv

Travel Advisory information provided and published with permission by IATA. (Timatic COVID-19 Alerts Service has been discontinued on 1/1/2022, please refer this page for latest travel advisory)

Austria Infection Trend


How can you tell if a curve is really flattening?

The number of daily confirmed cases has been used as an estimation of how severe the COVID-19 situation is in a given country. However, we’ve found that focusing on the country’s cumulative number of active cases gives a clearer picture of whether the infection curve is flattening.


Countries with Similar Characteristics


This table is generated by a GCI-developed tool to match countries based on their similar characteristics such as population, population density, income and climate.

Austria 34.46 33.06 8,877,067 Medium Density High income < 10 deg
Country Recovery Index Recovery Index Population Density GNI per capita Average Temperature
since First Case (Celsius)		 Match%
Denmark 60.27 54.63 5,818,553 Medium Density High income < 10 deg 100%
Estonia 34.34 41.29 1,326,590 Medium Density High income < 10 deg 100%
Ireland 66.93 61.79 4,941,444 Medium Density High income < 10 deg 100%
Latvia 30.93 23.77 1,912,789 Medium Density High income < 10 deg 100%
Lithuania 52.32 50.69 2,786,844 Medium Density High income < 10 deg 100%
Slovakia 65.08 72.52 5,454,073 Medium Density High income < 10 deg 100%
Slovenia 29.28 27.48 2,087,946 Medium Density High income < 10 deg 100%
Switzerland 48.32 41.62 8,574,832 Medium Density High income < 10 deg 100%
Croatia 60.06 64.27 4,067,500 Medium Density High income 11-20 deg 85%
Hungary 56.94 57.56 9,769,949 Medium Density High income 11-20 deg 85%

GCI Recovery Forecast


The GCI Recovery Forecasting methodology relies on a Monte Carlo simulation model as we recognise that the factors that contribute to an increase / decrease in confirmed COVID19 cases are highly variable and subject to various localised circumstances and interventions. The P10 / P50 / P90 are probabilities assigned to the forecasts, with P10 being highly optimistic, and P90 being very conservative on recovery and reduction in cases. The forecast model is updated daily based on the latest case data.

Forecast Results:

Situation May Improve. The GCI Model indicates that the situation has a small probability of recovery, but there is insufficient evidence to suggest that the recovery trend will improve significantly in the near future.




Reviewed and Endorsed by:

In Collaboration and
Partnership with:

image

Recognition and Award:

Chairman's Award



Key Sponsor:

image
image
image